1. Home
  2. FPI vs MYGN Comparison

FPI vs MYGN Comparison

Compare FPI & MYGN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Farmland Partners Inc.

FPI

Farmland Partners Inc.

HOLD

Current Price

$9.71

Market Cap

503.5M

Sector

Real Estate

ML Signal

HOLD

Logo Myriad Genetics Inc.

MYGN

Myriad Genetics Inc.

HOLD

Current Price

$5.28

Market Cap

444.2M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
FPI
MYGN
Founded
2013
1991
Country
United States
United States
Employees
N/A
N/A
Industry
Real Estate Investment Trusts
Biotechnology: In Vitro & In Vivo Diagnostic Substances
Sector
Real Estate
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
503.5M
444.2M
IPO Year
2013
1996

Fundamental Metrics

Financial Performance
Metric
FPI
MYGN
Price
$9.71
$5.28
Analyst Decision
Hold
Buy
Analyst Count
1
7
Target Price
N/A
$7.64
AVG Volume (30 Days)
385.2K
1.0M
Earning Date
04-29-2026
05-05-2026
Dividend Yield
3.14%
N/A
EPS Growth
N/A
N/A
EPS
0.01
N/A
Revenue
$52,178,000.00
$771,400,000.00
Revenue This Year
N/A
$6.86
Revenue Next Year
N/A
$5.45
P/E Ratio
$962.00
N/A
Revenue Growth
N/A
2.33
52 Week Low
$9.37
$3.53
52 Week High
$13.23
$8.59

Technical Indicators

Market Signals
Indicator
FPI
MYGN
Relative Strength Index (RSI) 49.24 43.98
Support Level $9.45 $4.24
Resistance Level $9.92 $5.52
Average True Range (ATR) 0.16 0.29
MACD 0.03 -0.13
Stochastic Oscillator 55.87 8.75

Price Performance

Historical Comparison
FPI
MYGN

About FPI Farmland Partners Inc.

Farmland Partners Inc owns and seeks to acquire high-quality farmland throughout North America. The company is an internally managed real estate company which owns and contracts farmland and storage facilities located across the United States. Majority of the properties in its portfolio are used to grow primary crops, such as corn, soybeans, wheat, rice and cotton, and rest to produce specialty crops, such as almonds, pictachios, citrus, avacados, strawberies, and edible beans. The company generates its revenues through the rent it receives from its tenants.

About MYGN Myriad Genetics Inc.

Myriad Genetics Inc is a molecular diagnostics and precision medicine company committed to advancing health and well-being for all. The company develops and commercializes molecular tests that help patients and providers uncover genetic insights. Its tests assess the risk of developing disease or disease progression and guide treatment decisions across medical specialties, supporting earlier detection, more precise treatment, and lowering healthcare costs. Its tests include BRACAnalysis CDx, EndoPredict, FirstGene, Foresight, GeneSight, MyChoice CDx, MyRisk (cancer treatment), MyRisk (cancer risk), Prequel, Precise Tumor, Prolaris, and SneakPeek. The company operates in the US and Rest of World, with maximum revenue from the US.

Share on Social Networks: